CSL Behring Plasma Product Transition
CSL Behring, New Zealand’s chosen national plasma fractionator, is changing manufacturing to new purpose-built facilities in Victoria, Australia. Using CSL’s global manufacturing processes, these new facilities will provide expanded capacity for producing New Zealand’s own domestic products, made from plasma collected by the New Zealand Blood Service.
Below you can access information on specific products that are being transitioned.